Search

Your search keyword '"Kocatürk, Emek"' showing total 388 results
Start Over Author "Kocatürk, Emek"
388 results on '"Kocatürk, Emek"'

4. Non–Skin Related Symptoms Are Common in Chronic Spontaneous Urticaria and Linked to Active and Uncontrolled Disease: Results From the Chronic Urticaria Registry

Author

Pyatilova, Polina, Hackler, Yana, Aulenbacher, Felix, Asero, Riccardo, Bauer, Andrea, Bizjak, Mojca, Day, Cascia, Dissemond, Joachim, Du-Thanh, Aurélie, Fomina, Daria, Giménez-Arnau, Ana M., Grattan, Clive, Gregoriou, Stamatis, Hawro, Tomasz, Kasperska-Zajac, Alicja, Khoshkhui, Maryam, Kocatürk, Emek, Kovalkova, Elena, Kulthanan, Kanokvalai, Kuznetsova, Elizaveta, Makris, Michael, Mukhina, Olga, Pesqué, David, Peter, Jonny, Salameh, Pascale, Siebenhaar, Frank, Sikora, Agnieszka, Staubach, Petra, Tuchinda, Papapit, Zamłyński, Mateusz, Weller, Karsten, Maurer, Marcus, and Kolkhir, Pavel

Published
2024
Full Text
View/download PDF

6. Patients With Chronic Spontaneous Urticaria Who Have Wheals, Angioedema, or Both, Differ Demographically, Clinically, and in Response to Treatment—Results From CURE

Author

Buttgereit, Thomas, Vera, Carolina, Aulenbacher, Felix, Church, Martin K., Hawro, Tomasz, Asero, Riccardo, Bauer, Andrea, Bizjak, Mojca, Bouillet, Laurence, Dissemond, Joachim, Fomina, Daria, Giménez-Arnau, Ana M., Grattan, Clive, Gregoriou, Stamatios, Kulthanan, Kanokvalai, Kasperska-Zajac, Alicja, Kocatürk, Emek, Makris, Michael, Kolkhir, Pavel, Weller, Karsten, Magerl, Markus, and Maurer, Marcus

Published
2023
Full Text
View/download PDF

7. Urticaria exacerbations and adverse reactions in patients with chronic urticaria receiving COVID-19 vaccination: Results of the UCARE COVAC-CU study

Author

Kocatürk, Emek, Salameh, Pascale, Sarac, Esra, Vera Ayala, Carolina E., Thomsen, Simon Francis, Zuberbier, Torsten, Ensina, Luis Felipe, Popov, Todor A., van Doorn, Martijn B.A., Giménez-Arnau, Ana Maria, Asero, Riccardo, Criado, Paulo Ricardo, Aarestrup, Fernando M., AbdulHameed Ansari, Zainab, Al Abri, Salma, Al-Ahmad, Mona, Al Hinai, Bushra, Allenova, Anastasiia, Al-Nesf, Maryam, Altrichter, Sabine, Arnaout, Rand, Bartosińska, Joanna, Bauer, Andrea, Bernstein, Jonathan A., Bizjak, Mojca, Bonnekoh, Hanna, Bouillet, Laurence, Brzoza, Zenon, Calvalcanti Dela Bianca Melo, Ana Caroline, Campinhos, Fernanda L., Carne, Emily, Purayil, Saleema Cherichi, Cherrez-Ojeda, Ivan, Chong-Neto, Herberto Jose, Christoff, George, Conlon, Niall, Jardim Criado, Roberta Fachini, Cvenkel, Klara, Damadoglu, Ebru, Danilycheva, Inna, Day, Cascia, de Montjoye, Laurence, Demir, Semra, Ferucci, Silvia Mariel, Fomina, Daria, Fukunaga, Atsushi, Garcia, Elizabeth, Gelincik, Asli, Göbel, Joe Hannah, Godse, Kiran, Gonçalo, Margarida, Gotua, Maia, Grattan, Clive, Gugala, Agata, Guillet, Carole, Kalyoncu, Ali Fuat, Karakaya, Gul, Kasperska-Zając, Alicja, Katelaris, Constance H., Khoshkhui, Maryam, Kleinheinz, Andreas, Kolacinska-Flont, Marta, Kolkhir, Pavel, Košnik, Mitja, Krasowska, Dorota, Kumaran, Muthu Sendhil, Kuprys-Lipinska, Izabela, Kurowski, Marcin, Kuznetsova, Elizaveta V., Larenas-Linnemann, Désirée, Lebedkina, Marina S., Lee, Youngsoo, Makris, Michael, Gómez, René Maximiliano, Nasr, Iman, Neisinger, Sophia, Oda, Yoshiko, Kara, Rabia Öztaş, Palitot, Esther Bastos, Papapostolou, Niki, Salvador Parisi, Claudio Alberto, Pesque, David, Peter, Jonathan, Petkova, Elena, Ridge, Katie, Rudenko, Michael, Rutkowski, Krzysztof, Saini, Sarbjit S., Salman, Andac, Sanchez, Jorge, Şekerel, Bülent, Serdotetskova, Sofia A., Serpa, Faradiba S., Dikicier, Bahar Sevimli, Sidiropoulos, Nikitas, Sikora, Agnieszka, Sørensen, Jennifer Astrup, Soria, Angele, Kucuk, Ozlem Su, Thalappil, Sherin Rahim, Tomaszewska, Katarzyna, Tuncay, Gulseren, Unal, Derya, Valle, Solange, van Lindonk, Esmee, Vestergaard, Christian, Meshkova, Raisa Y., Vitchuk, Aleksandr, Xepapadaki, Paraskevi, Ye, Young-Min, Zalewska-Janowska, Anna, Zamlynski, Mateusz, and Maurer, Marcus

Published
2023
Full Text
View/download PDF

8. Urticarial Vasculitis Differs From Chronic Spontaneous Urticaria in Time to Diagnosis, Clinical Presentation, and Need for Anti-Inflammatory Treatment: An International Prospective UCARE Study

Author

Bonnekoh, Hanna, Jelden-Thurm, Jannis, Allenova, Anastasiia, Chen, Yudi, Cherrez-Ojeda, Ivan, Danilycheva, Inna, Dorofeeva, Irina, Jardim Criado, Roberta Fachini, Criado, Paulo Ricardo, Gelincik Akkor, Asli, Hawro, Tomasz, Kocatürk, Emek, Khoshkhui, Maryam, Metz, Martin, Nasr, Iman, Steć, Michał, Zhao, Zuotao, Aulenbacher, Felix, Salameh, Pascale, Altrichter, Sabine, Gonçalo, Margarida, Gimenez-Arnau, Ana, Maurer, Marcus, Krause, Karoline, and Kolkhir, Pavel

Published
2023
Full Text
View/download PDF

11. The Benefit of Complete Response to Treatment in Patients With Chronic Spontaneous Urticaria—CURE Results

Author

Kolkhir, Pavel, Laires, Pedro A., Salameh, Pascale, Asero, Riccardo, Bizjak, Mojca, Košnik, Mitja, Dissemond, Joachim, van Doorn, Martijn, Hawro, Tomasz, Kasperska-Zajac, Alicja, Zajac, Magdalena, Kocatürk, Emek, Peter, Jonny, Parisi, Claudio A.S., Ritchie, Carla A., Kulthanan, Kanokvalai, Tuchinda, Papapit, Fomina, Daria, Kovalkova, Elena, Khoshkhui, Maryam, Kouzegaran, Samaneh, Papapostolou, Niki, Du-Thanh, Aurélie, Kamegashira, Akiko, Meshkova, Raisa, Vitchuk, Alexander, Bauer, Andrea, Grattan, Clive, Staubach, Petra, Bouillet, Laurence, Giménez-Arnau, Ana M., Maurer, Marcus, and Weller, Karsten

Published
2023
Full Text
View/download PDF

12. Non-Skin-Related Symptoms are Common in Chronic Spontaneous Urticaria and Linked to Active and Uncontrolled Disease: Results from CURE

Author

Pyatilova, Polina, primary, Hackler, Yana, additional, Aulenbacher, Felix, additional, Asero, Riccardo, additional, Bauer, Andrea, additional, Bizjak, Mojca, additional, Day, Cascia, additional, Dissemond, Joachim, additional, Du-Thanh, Aurélie, additional, Fomina, Daria, additional, Giménez-Arnau, Ana M., additional, Grattan, Clive, additional, Gregoriou, Stamatis, additional, Hawro, Tomasz, additional, Kasperska-Zajac, Alicja, additional, Khoshkhui, Maryam, additional, Kocatürk, Emek, additional, Kovalkova, Elena, additional, Kulthanan, Kanokvalai, additional, Kuznetsova, Elizaveta, additional, Makris, Michael, additional, Mukhina, Olga, additional, Pesqué, David, additional, Peter, Jonny, additional, Salameh, Pascale, additional, Siebenhaar, Frank, additional, Sikora, Agnieszka, additional, Staubach, Petra, additional, Tuchinda, Papapit, additional, Zamłyński, Mateusz, additional, Weller, Karsten, additional, Maurer, Marcus, additional, and Kolkhir, Pavel, additional

Published
2024
Full Text
View/download PDF

16. Plasma proteomics analysis of patients with chronic spontaneous urticaria reveals significant associations with key disease characteristics but not with response to omalizumab treatment.

Author

Ghazanfar, Misbah Noshela, Petrosius, Valdemaras, Sørensen, Jennifer Astrup, Zhang, Ditte Georgina, Ali, Zarqa, Maurer, Marcus, Kocatürk, Emek, Nielsen, Valdemar Wendelboe, Savickas, Simonas, Keller, Ulrich auf dem, Schoof, Erwin M., and Thomsen, Simon Francis

Subjects
HEAT shock proteins, PATIENTS, PREGNANCY proteins, PROTEOMICS, BLOOD proteins, URTICARIA, AUTOIMMUNE diseases
Abstract

This article discusses a study that aimed to identify potential biomarkers for chronic spontaneous urticaria (CSU), a skin disease characterized by severe itching. The researchers collected blood samples from 118 CSU patients and analyzed the plasma proteomics to identify associations with key disease characteristics. They found that certain plasma proteins were significantly associated with clinical traits such as sex, positive basophil histamine release assay (BHRA), angioedema, and concomitant chronic inducible urticaria (CIndU). However, these proteins were not associated with the response to omalizumab treatment, which is commonly used as a second-line treatment for CSU. The findings provide insights into the molecular mechanisms underlying CSU and may contribute to personalized management of the disease. The document is a list of acknowledgements and conflict of interest statements for the study, with no conflicts of interest reported by the authors. Two graphs labeled "Data S1" and "Data S2" are included. [Extracted from the article]

Published
2024
Full Text
View/download PDF

17. Monitoring recurrent angioedema: Findings from the Turkish angioedema control test validation study

Author

Demir, Semra, primary, Eyice‐Karabacak, Deniz, additional, Kocatürk, Emek, additional, Ünal, Derya, additional, Toprak, İlkim Deniz, additional, Korkmaz, Pelin, additional, Aslan, Ayşe Feyza, additional, İmren, Işıl Göğem, additional, Dikicier, Bahar, additional, Kahveci, Nevzat, additional, Öztop, Nida, additional, Kara, Rabia Öztaş, additional, İşsever, Halim, additional, Maurer, Marcus, additional, Weller, Karsten, additional, and Gelincik, Aslı, additional

Published
2024
Full Text
View/download PDF

18. A global perspective on stepping down chronic spontaneous urticaria treatment: Results of the Urticaria Centers of Reference and Excellence SDown‐CSU study

Author

Türk, Murat, primary, Kocatürk, Emek, additional, Ertaş, Ragıp, additional, Ensina, Luis Felipe, additional, Mariel Ferrucci, Silvia, additional, Grattan, Clive, additional, Vestergaard, Christian, additional, Zuberbier, Torsten, additional, Maurer, Marcus, additional, and Giménez‐Arnau, Ana Maria, additional

Published
2024
Full Text
View/download PDF

19. Urticaria Patients Are Highly Interested in Apps to Monitor Their Disease Activity and Control: A UCARE CURICT Analysis

Author

Cherrez-Ojeda, Ivan, primary, Vanegas, Emanuel, additional, Cherrez, Annia, additional, Felix, Miguel, additional, Weller, Karsten, additional, Magerl, Markus, additional, Maurer, Rasmus, additional, MATA, Valeria L, additional, Kasperska-Zając, Alicja, additional, SIKORA, Agnieszka, additional, Fomina, Daria, additional, KOVALKOVA, Elena, additional, Godse, Kiran, additional, RAO, Nimmagadda Dheeraj, additional, Khoshkhui, Maryam, additional, RASTGOO, Sahar, additional, Criado, Roberta, additional, Abuzakouk, Mohamed, additional, GRANDON, Deepa, additional, Doorn, Martijn van, additional, Valle, Solange, additional, Lima, Eduardo M. de Souza, additional, Thomsen, Simon Francis, additional, Ramón, German, additional, BENAVIDES, Edgar Matos E, additional, Bauer, Andrea, additional, Arnau, Ana Giménez, additional, Kocatürk, Emek, additional, Guillet, Carole, additional, Larco, Jose Ignacio, additional, Zhao, Zuotao, additional, Makris, Michael, additional, RITCHIE, Carla, additional, XEPAPADAKI, PARASKEVI, additional, Ensina, Luis, additional, CHERREZ, Sofia, additional, and Maurer, Marcus, additional

Published
2024
Full Text
View/download PDF

20. CRUSE®—An innovative mobile application for patient monitoring and management in chronic spontaneous urticaria

Author

Neisinger, Sophia, primary, Sousa Pinto, Bernardo, additional, Ramanauskaite, Aiste, additional, Bousquet, Jean, additional, Weller, Karsten, additional, Metz, Martin, additional, Magerl, Markus, additional, Kocatürk, Emek, additional, Cherrez‐Ojeda, Ivan, additional, Gimenez‐Arnau, Ana M., additional, Parisi, Claudio Alberto S., additional, Altrichter, Sabine, additional, Ensina, Luis Felipe, additional, Bouillet, Laurence, additional, Asero, Riccardo, additional, Gonçalo, Margarida, additional, Guillet, Carole, additional, Rutkowski, Krzysztof, additional, Bernstein, Jonathan A., additional, Hardin, Hannah, additional, Godse, Kiran, additional, Brzoza, Zenon, additional, Sousa, Jose Ignacio Larco, additional, Thomsen, Simon Francis, additional, van Doorn, Martijn, additional, Hide, Michihiro, additional, Ye, Young‐Min, additional, Vanderse, Staffan, additional, Lapiņa, Lāsma, additional, Peter, Jonny, additional, Zhao, Zuotao, additional, Han, Lianyi, additional, Nasr, Iman, additional, Rockmann‐Helmbach, Heike, additional, Sørensen, Jennifer Astrup, additional, Kara, Rabia Öztaş, additional, Kurjāne, Natalja, additional, Kurchenko, Andrii I., additional, Kaidashev, Igor, additional, Tsaryk, Vladyslav, additional, Stepanenko, Roman, additional, and Maurer, Marcus, additional

Published
2024
Full Text
View/download PDF

22. How are patients with chronic urticaria interested in using information and communication technologies to guide their healthcare? A UCARE study

Author

Cherrez-Ojeda, Ivan, Vanegas, Emanuel, Cherrez, Annia, Felix, Miguel, Weller, Karsten, Magerl, Markus, Maurer, Rasmus Robin, Mata, Valeria L., Kasperska-Zajac, Alicja, Sikora, Agnieszka, Fomina, Daria, Kovalkova, Elena, Godse, Kiran, Rao, Nimmagadda Dheeraj, Khoshkhui, Maryam, Rastgoo, Sahar, Criado, Roberta FJ., Abuzakouk, Mohamed, Grandon, Deepa, Van Doorn, Martijn B.A., Oliveira Rodrigues Valle, Solange, De Souza Lima, Eduardo Magalhães, Thomsen, Simon Francis, Ramón, German D., Matos Benavides, Edgar E., Bauer, Andrea, Giménez-Arnau, Ana M., Kocatürk, Emek, Guillet, Carole, Larco, Jose Ignacio, Zhao, Zuo-Tao, Makris, Michael, Ritchie, Carla, Xepapadaki, Paraskevi, Ensina, Luis Felipe, Cherrez, Sofia, and Maurer, Marcus

Published
2021
Full Text
View/download PDF

23. The usage, quality and relevance of information and communications technologies in patients with chronic urticaria: A UCARE study

Author

Maurer, Marcus, Weller, Karsten, Magerl, Markus, Maurer, Rasmus Robin, Vanegas, Emanuel, Felix, Miguel, Cherrez, Annia, Mata, Valeria L., Kasperska-Zajac, Alicja, Sikora, Agnieszka, Fomina, Daria, Kovalkova, Elena, Godse, Kiran, Rao, Nimmagadda Dheeraj, Khoshkhui, Maryam, Rastgoo, Sahar, Criado, Roberta Fachini Jardim, Abuzakouk, Mohamed, Grandon, Deepa, van Doorn, Martijn, Valle, Solange Olliveira Rodrigues, de Souza Lima, Eduardo Magalhães, Thomsen, Simon Francis, Ramón, German D., Matos Benavides, Edgar E., Bauer, Andrea, Giménez-Arnau, Ana Maria, Kocatürk, Emek, Guillet, Carole, Ignacio Larco, Jose, Zhao, Zuo-Tao, Makris, Michael, Ritchie, Carla, Xepapadaki, Paraskevi, Ensina, Luis Felipe, Cherrez, Sofia, and Cherrez-Ojeda, Ivan

Published
2020
Full Text
View/download PDF

24. Online Depiction of Urticaria Is Often Flawed and Does Not Reflect the Spectrum of Clinical Manifestation.

Author

Zhang, Ditte Georgina, Sørensen, Jennifer Astrup, Pedersen, Nadja Højgaard, Ali, Zarqa, Kocatürk, Emek, Maurer, Marcus, and Thomsen, Simon Francis

Subjects
URTICARIA, SYMPTOMS, DELAYED diagnosis, SEARCH engines, PHYSICIANS, ANGIONEUROTIC edema
Abstract

Introduction: The internet is a popular source of health information including images of disease manifestations. Online photographs of skin lesions may aid patients in identifying their disease, if these pictures are of good quality and of the disease they claim to show. If not, patients may be at risk of delayed diagnosis, misdiagnosis, and suboptimal treatment. For urticaria, the mismatch rate and quality of online pictures are unknown. The objective of this study was therefore to evaluate the content and quality of online images of urticaria. Methods: The search term "urticaria" was applied to Google Images and Shutterstock. The top 100 photographs from each search engine were retrieved on October 9th, 2022. Illustrations, drawings, and heavily edited photographs were excluded. Each image was evaluated for patient characteristics, characteristics of urticarial lesions, and image quality. Results: Across 194 unique images of urticaria (after removing duplicates), 35 (18.0%) did not depict urticarial lesions, and 38 (19.6%) were ambiguous. Less than two-thirds of images 121 (62.4%) showed bona fide urticarial lesions. Pictures of urticarial lesions under-represented children and did not reflect female preponderance of the disease. Images predominantly depicted urticaria lesions on Caucasian skin (59.8%) and were typical of spontaneous rather than inducible urticaria. Only 3 (1.5%) pictures showed angioedema, a common clinical sign in patients with urticaria. The overall quality of online urticaria pictures was mostly good or very good. Conclusion: Physicians and patients should be aware that one in five online pictures of urticaria does not show urticarial skin lesions, and children, females, non-Caucasian patients, inducible urticaria, and angioedema are under-represented. These findings should prompt efforts to improve the accuracy and representativeness of online urticaria pictures. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

25. Smartphone Photographs of Chronic Urticaria Taken by Patients Are of Good Quality and Useful in the Clinic.

Author

Ali, Zarqa, Sørensen, Jennifer Astrup, Zhang, Ditte Georgina, Ghazanfar, Misbah Noshela, Allerup, Johan Anker Chrom, Maurer, Marcus, Kocatürk, Emek, Vestergaard, Christian, and Thomsen, Simon Francis

Subjects
SMARTPHONES, PHOTOGRAPHS, URTICARIA, ANGIONEUROTIC edema
Abstract

Background: Chronic urticaria (CU) is characterized by transient wheals and angioedema, which are often not present when patients see their treating physician. Objective: The objective of this study was to evaluate the diagnostic value of smartphone photographs captured by patients prior to their first visit at an urticaria outpatient clinic. Methods: A survey regarding the quality and utility of smartphone photographs of urticarial skin lesions in patients with CU attending the outpatient clinic for the first time was conducted. Up to three random patient-selected photographs of skin lesions were evaluated by a physician. Results: Of 148 patients, 118 (79.7%) had taken photographs of their skin lesions prior to the consultation, and 75% took photographs with the intention of presenting it to their physician. The photographs were of wheals in 90% of the cases and angioedema in 8%. In total, 72% of the smartphone photographs had the skin lesion in focus, 64% had good resolution, and 48% had good lighting. Only 9% of the smartphone photographs were blurred, 10% had bad lighting, 4% had bad resolution, and 8% did not have the lesion in focus. Moreover, 86% of the smartphone photographs were found to be useful for clinical evaluation. At least one photograph of good/very good quality was presented by 86% of the patients, and 97% had at least one photograph that was useful for clinical evaluation. Conclusion: Patients with CU often take smartphone photographs of their skin lesions on their own initiative prior to their first consultation to present the photographs to their physician. These smartphone photographs are very often of good quality and suitable for clinical evaluation. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

26. An update on the use of antihistamines in managing chronic urticaria.

Author

Xiang, Yi-Kui, Fok, Jie Shen, Podder, Indrashis, Yücel, Muhammed Burak, Özkoca, Defne, Thomsen, Simon Francis, and Kocatürk, Emek

Subjects
ANTIHISTAMINES, URTICARIA, SKIN diseases, GENOMICS, MOLECULAR genetics
Abstract

Urticaria, a mast cell-mediated skin disease, manifests as acute or chronic, with the latter divided into spontaneous and inducible types and requires individualized management, including identifying triggers and comorbidities. Antihistamines, particularly the second generation group, form the mainstay of primary treatment plans consisting of dosage adjustments and/or in combination with other treatment modalities depending on underlying disease control. A literature search was conducted using 'antihistamines,' 'urticaria,' 'pharmacogenomics,' 'genomics,' 'biomarkers' and 'treatment response' as key words. In this review, we focus on the comprehensive understanding and application of antihistamines in managing adult and adolescent patients with chronic urticaria. Using antihistamines to treat urticaria is set to change significantly, focusing more on personalized medicine and identifying key biomarkers to enhance treatment response prediction. These changes aim to make treatments more specific and cost-effective by avoiding unnecessary tests. Applying new approaches in everyday clinical care faces challenges like proving the biomarkers' reliability, updating current guidelines, and incorporating individualized treatments into standard procedures. Efforts should now concentrate on finding easy-to-use biomarkers, improving access to pharmacogenomics, understanding why some patients are resistant to treatment, and creating more specific treatment options based on patient needs. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

30. Differential diagnosis between urticarial vasculitis and chronic spontaneous urticaria: An international Delphi survey

Author

Krause, Karoline, primary, Bonnekoh, Hanna, additional, Jelden‐Thurm, Jannis, additional, Asero, Riccardo, additional, Gimenez‐Arnau, Ana Maria, additional, Cardoso, José C., additional, Grattan, Clive, additional, Kocatürk, Emek, additional, Lippert, Undine, additional, Maurer, Marcus, additional, Metz, Martin, additional, Staubach, Petra, additional, Goncalo, Margarida, additional, and Kolkhir, Pavel, additional

Published
2023
Full Text
View/download PDF

34. CRUSE®—An innovative mobile application for patient monitoring and management in chronic spontaneous urticaria.

Author

Neisinger, Sophia, Sousa Pinto, Bernardo, Ramanauskaite, Aiste, Bousquet, Jean, Weller, Karsten, Metz, Martin, Magerl, Markus, Kocatürk, Emek, Cherrez‐Ojeda, Ivan, Gimenez‐Arnau, Ana M., Parisi, Claudio Alberto S., Altrichter, Sabine, Ensina, Luis Felipe, Bouillet, Laurence, Asero, Riccardo, Gonçalo, Margarida, Guillet, Carole, Rutkowski, Krzysztof, Bernstein, Jonathan A., and Hardin, Hannah

Subjects
PATIENT monitoring, URTICARIA, PATIENT reported outcome measures, SELF-evaluation, SYMPTOMS
Abstract

Background: Chronic spontaneous urticaria (CSU) is unpredictable and can severely impair patients' quality of life. Patients with CSU need a convenient, user‐friendly platform to complete patient‐reported outcome measures (PROMs) on their mobile devices. CRUSE®, the Chronic Urticaria Self Evaluation app, aims to address this unmet need. Methods: CRUSE® was developed by an international steering committee of urticaria specialists. Priorities for the app based on recent findings in CSU were defined to allow patients to track and record their symptoms and medication use over time and send photographs. The CRUSE® app collects patient data such as age, sex, disease onset, triggers, medication, and CSU characteristics that can be sent securely to physicians, providing real‐time insights. Additionally, CRUSE® contains PROMs to assess disease activity and control, which are individualised to patient profiles and clinical manifestations. Results: CRUSE® was launched in Germany in March 2022 and is now available for free in 17 countries. It is adapted to the local language and displays a country‐specific list of available urticaria medications. English and Ukrainian versions are available worldwide. From July 2022 to June 2023, 25,710 observations were documented by 2540 users; 72.7% were females, with a mean age of 39.6 years. At baseline, 93.7% and 51.3% of users had wheals and angioedema, respectively. Second‐generation antihistamines were used in 74.0% of days. Conclusions: The initial data from CRUSE® show the wide use and utility of effectively tracking patients' disease activity and control, paving the way for personalised CSU management. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

35. A concept for integrated care pathways for atopic dermatitis—A GA2LEN ADCARE initiative

Author

Zuberbier, Torsten, primary, Abdul Latiff, Amir, additional, Aggelidis, Xenofon, additional, Augustin, Matthias, additional, Balan, Radu‐Gheorghe, additional, Bangert, Christine, additional, Beck, Lisa, additional, Bieber, Thomas, additional, Bernstein, Jonathan A., additional, Bertolin Colilla, Marta, additional, Berardi, Alejandro, additional, Bedbrook, Anna, additional, Bindslev‐Jensen, Carsten, additional, Bousquet, Jean, additional, de Bruin‐Weller, Marjolein, additional, Bruscky, Dayanne, additional, Buyuktiryaki, Betul, additional, Canonica, Giorgio Walter, additional, Castro, Carla, additional, Chanturidze, Natia, additional, Chong‐Neto, Herberto Jose, additional, Chu, Chia‐Yu, additional, Chularojanamontri, Leena, additional, Cork, Michael, additional, Criado, Roberta F. J., additional, Barredo, Laia Curto, additional, Custovic, Adnan, additional, Darsow, Ulf, additional, Emurlai, Arben, additional, de Pablo, Ana, additional, Del Giacco, Stefano, additional, Girolomoni, Giampiero, additional, Deleva Jovanova, Tanja, additional, Deleuran, Mette, additional, Douladiris, Nikolaos, additional, Duarte, Bruno, additional, Dubakiene, Ruta, additional, Eller, Esben, additional, Engel‐Yeger, Batya, additional, Ensina, Luis Felipe, additional, Filho, Nelson Rosario, additional, Flohr, Carsten, additional, Fomina, Daria, additional, Francuzik, Wojciech, additional, Galimberti, Maria Laura, additional, Giménez‐Arnau, Ana M., additional, Godse, Kiran, additional, Mortz, Charlotte Gotthard, additional, Gotua, Maia, additional, Hide, Michihiro, additional, Hoetzenecker, Wolfram, additional, Hunzelmann, Nicolas, additional, Irvine, Alan, additional, Jack, Carolyn, additional, Kanavarou, Ioanna, additional, Katoh, Norito, additional, Kinaciyan, Tamar, additional, Kocatürk, Emek, additional, Kulthanan, Kanokvalai, additional, Lapeere, Hilde, additional, Lau, Susanne, additional, Machado Forti Nastri, Mariana, additional, Makris, Michael, additional, Mansour, Eli, additional, Marsland, Alexander, additional, Morelo Rocha Felix, Mara, additional, Moschione Castro, Ana Paula, additional, Nettis, Eustachio, additional, Nicolas, J. F., additional, Nosbaum, Audrey, additional, Odemyr, Mikaela, additional, Papapostolou, Niki, additional, Parisi, Claudio A. S., additional, Paudel, Sushil, additional, Peter, Jonny, additional, Pokharel, Prakash, additional, Puig, Luis, additional, Quint, Tamara, additional, Ramon, German Dario, additional, Regateiro, Frederico, additional, Ricci, Giampaolo, additional, Rosario, Cristine, additional, Sackesen, Cansin, additional, Schmid‐Grendelmeier, Peter, additional, Serra‐Baldrich, Esther, additional, Siemens, Kristina, additional, Smith, Cathrine, additional, Staubach, Petra, additional, Stevanovic, Katarina, additional, Su‐Kücük, Özlem, additional, Sussman, Gordon, additional, Tavecchio, Simona, additional, Teovska Mitrevska, Natasa, additional, Thaci, Diamant, additional, Toubi, Elias, additional, Traidl‐Hoffmann, Claudia, additional, Treudler, Regina, additional, Vadasz, Zahava, additional, van Hofman, Ingrid, additional, Ventura, Maria Teresa, additional, Wang, Zhao, additional, Werfel, Thomas, additional, Wollenberg, Andreas, additional, Yang, Ariana, additional, Weng Yew, Yik, additional, Zhao, Zuotao, additional, Zwiener, Ricardo, additional, and Worm, Margitta, additional

Published
2023
Full Text
View/download PDF

36. How Infection and Vaccination Are Linked to Acute and Chronic Urticaria: A Special Focus on COVID-19

Author

Kocatürk, Emek, primary, Muñoz, Melba, additional, Elieh-Ali-Komi, Daniel, additional, Criado, Paulo Ricardo, additional, Peter, Jonny, additional, Kolkhir, Pavel, additional, Can, Pelin, additional, Wedi, Bettina, additional, Rudenko, Michael, additional, Gotua, Maia, additional, Ensina, Luis Felipe, additional, Grattan, Clive, additional, and Maurer, Marcus, additional

Published
2023
Full Text
View/download PDF

38. Existing and Investigational Medications for Refractory Chronic Spontaneous Urticaria: Safety, Adverse Effects, and Monitoring

Author

Kocatürk, Emek, Saini, Sarbjit Singh, Rubeiz, Christine J., Bernstein, Jonathan A., and Publica

Subjects
Monitoring, Urticaria, Drug-Related Side Effects and Adverse Reactions, Adverse effects, Omalizumab, Biologics, Chronic spontaneous urticaria, Immunosuppressants, Alternative treatments, Chronic Disease, Histamine H1 Antagonists, Anti-inflammatory medications, H1 antihistamines, Humans, Immunology and Allergy, Chronic Urticaria, Safety
Abstract

Treatment of chronic spontaneous urticaria (CSU) is responsive to H1 antihistamines administered up to four times the recommended US Food and Drug Administration dose in approximately 50% of patients. However, when patients do not respond to these first-line agents, evidence-based guidelines using Grading of Recommendations, Assessment, Development, and Evaluations methodology have provided direction for second- and third-line treatments that can effectively treat patients with CSU. Some patients remain refractory to these advanced treatments; therefore, alternative treatments with a lower certainty of evidence may be necessary. Regardless of the therapies used to treat CSU patients, it is essential for clinicians to be knowledgeable about the mechanism of action, efficacy, and safety and monitoring recommendations of the treatments prescribed. This review provides a comprehensive review of the adverse effects and monitoring recommendations for agents in use for CSU treatment as well as those currently undergoing investigation for CSU treatment.

Published
2022

40. CRUSE – What the first 100 days have taught us

Author

Neisinger, Sophia, primary, Pinto, Bernardo Sousa, additional, Ramanauskaite, Aiste, additional, Bousquet, Jean, additional, Weller, Karsten, additional, Metz, Martin, additional, Magerl, Markus, additional, Kocatürk, Emek, additional, Ojeda, Ivan Cherrez, additional, Gimenez-Arnau, Ana M, additional, and Maurer, Marcus, additional

Published
2023
Full Text
View/download PDF

47. Total IgE levels are linked to the course of chronic spontaneous urticaria during pregnancy

Author

Kocatürk, Emek, primary, Thomsen, Simon Francis, additional, Al-Ahmad, Mona, additional, Gimenez Arnau, Ana M., additional, Conlon, Niall, additional, Şavk, Ekin, additional, Jardim Criado, Roberta Fachini, additional, Danilycheva, Inna, additional, Fomina, Daria, additional, Khoshkhui, Maryam, additional, Gelincik, Aslı, additional, Yüksel, Ece Nur, additional, Ertan, Semra, additional, Ensina, Luis Felipe, additional, Kasperska-Zajac, Alicja, additional, Rudenko, Michael, additional, Bauer, Andrea, additional, Medina, Iris V., additional, and Maurer, Marcus, additional

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results